Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Oct;22(4):686–688. doi: 10.1128/aac.22.4.686

Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.

Y R Bilgeri, R C Ballard, M O Duncan, A C Mauff, H J Koornhof
PMCID: PMC183814  PMID: 6983858

Abstract

Of 103 strains of Haemophilus ducreyi isolated in Johannesburg, 96 produced beta-lactamase and were resistant to penicillin and ampicillin. Most strains showed resistance to tetracycline, sulfisoxazole, and sulfamethoxazole. All isolates were susceptible to rifampin, erythromycin, and cefoxitin, moderately susceptible to trimethoprim-sulfamethoxazole (1:19) and minocycline, and somewhat less susceptible to doxycycline.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunton J. L., Maclean I., Ronald A. R., Albritton W. L. Plasmid-mediated ampicillin resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1979 Feb;15(2):294–299. doi: 10.1128/aac.15.2.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carpenter J. L., Back A., Gehle D., Oberhoffer T. Treatment of chancroid with erythromycin. Sex Transm Dis. 1981 Jul-Sep;8(3):192–197. doi: 10.1097/00007435-198107000-00004. [DOI] [PubMed] [Google Scholar]
  3. Feltham S., Ronald A. R., Albritton W. L. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains. J Antimicrob Chemother. 1979 Nov;5(6):731–734. doi: 10.1093/jac/5.6.731. [DOI] [PubMed] [Google Scholar]
  4. Hafiz S., Kinghorn G. R., McEntegart M. G. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium. Br J Vener Dis. 1981 Dec;57(6):382–386. doi: 10.1136/sti.57.6.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother. 1978 Apr;13(4):608–612. doi: 10.1128/aac.13.4.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hammond G. W., Lian C. J., Wilt J. C., Ronald A. R. Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi. J Clin Microbiol. 1978 Jan;7(1):39–43. doi: 10.1128/jcm.7.1.39-43.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hammond G. W., Slutchuk M., Lian C. J., Wilt J. C., Ronald A. R. The treatment of chancroid: comparison of one week of sulfisoxazole with single dose doxycycline. J Antimicrob Chemother. 1979 May;5(3):261–265. doi: 10.1093/jac/5.3.261. [DOI] [PubMed] [Google Scholar]
  8. Kerber R. E., Rowe C. E., Gilbert K. R. Treatment of chancroid. A comparison of tetracycline and sulfisoxazole. Arch Dermatol. 1969 Nov;100(5):604–607. [PubMed] [Google Scholar]
  9. Kilian M. A taxonomic study of the genus Haemophilus, with the proposal of a new species. J Gen Microbiol. 1976 Mar;93(1):9–62. doi: 10.1099/00221287-93-1-9. [DOI] [PubMed] [Google Scholar]
  10. Lykke-Olesen L., Larsen L., Pedersen T. G., Gaarslev K. Epidemic of chancroid in Greenland 1977-78. Lancet. 1979 Mar 24;1(8117):654–655. doi: 10.1016/s0140-6736(79)91091-2. [DOI] [PubMed] [Google Scholar]
  11. MacLean I. W., Bowden G. H., Albritton W. L. TEM-type beta-lactamase production in Haemophilus ducreyi. Antimicrob Agents Chemother. 1980 May;17(5):897–900. doi: 10.1128/aac.17.5.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Marmar J. L. The management of resistant chancroid in Vietnam. J Urol. 1972 May;107(5):807–808. doi: 10.1016/s0022-5347(17)61144-3. [DOI] [PubMed] [Google Scholar]
  13. Medeiros A. A., O'Brien T. F. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet. 1975 Mar 29;1(7909):716–719. doi: 10.1016/s0140-6736(75)91630-x. [DOI] [PubMed] [Google Scholar]
  14. Nsanze H., Fast M. V., D'Costa L. J., Tukei P., Curran J., Ronald A. Genital ulcers in Kenya. Clinical and laboratory study. Br J Vener Dis. 1981 Dec;57(6):378–381. doi: 10.1136/sti.57.6.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Richmond M. H., Curtis N. A. The interplay of beta-lactamases and intrinsic factors in the resistance of gram-negative bacteria to penicillins and cephalosporins. Ann N Y Acad Sci. 1974 May 10;235(0):553–568. doi: 10.1111/j.1749-6632.1974.tb43290.x. [DOI] [PubMed] [Google Scholar]
  17. Rudolph A. H. Antibiotic treatment of the venereal diseases--update 1979. Int J Dermatol. 1979 Dec;18(10):797–804. doi: 10.1111/j.1365-4362.1979.tb04466.x. [DOI] [PubMed] [Google Scholar]
  18. Thomson J. A., Bilgeri Y. R. Plasmid-coded ampicillin resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Oct;22(4):689–692. doi: 10.1128/aac.22.4.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilkinson P. J., Reeves D. S. Tissue penetration of trimethoprim and sulphonamides. J Antimicrob Chemother. 1979 Nov;5(B):159–168. doi: 10.1093/jac/5.supplement_b.159. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES